Status:

UNKNOWN

Autologous Micrografts From the Palatal Mucosa for Periodontal Regeneration

Lead Sponsor:

University of Turin, Italy

Conditions:

Periodontitis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Some research studies have demonstrated that autologous micrografts made out of different oral tissues may enhance tissue regeneration. The primary aim of this study is to evaluate the clinical perfor...

Eligibility Criteria

Inclusion

  • Patients selected for the study should fulfil the following inclusion criteria:
  • Affected from stage III-IV periodontitis.
  • Completed non-surgical periodontal therapy.
  • FMPS \<15% at 3-month re-evaluation.
  • FMBS \<15% at 3-month re-evaluation.
  • At least one site with an interproximal intrabony defects and residual PPD ≥ 6 mm at re-evaluation, with a radiographic intrabony component ≥ 3 mm, extending to the lingual/palatal side as assessed by preoperative bone sounding.
  • Intrasurgically, the defect has to present a non-supporting anatomy (1-2 residual walls in its most coronal portion), requiring flap elevation on both buccal and oral side for its accessibility.
  • Signed informed consent.
  • Exclusion criteria:
  • Compromised general health which contraindicates the study procedures (ASA III-VI patients).
  • Systemic diseases/medications which could influence the outcome of the therapy (e.g. uncontrolled diabetes mellitus, non-plaque-induced gingival diseases, antiepileptic drugs (phenytoin and sodium valproate), certain calcium channel-blocking drugs (e.g., nifedipine, verapamil, diltiazem, amlodipine, felodipine), immunoregulatory drugs (e.g., cyclosporine), and high-dose oral contraceptives.
  • Current smokers (self-reported), users of chewing tobacco, and drug/alcohol abusers.
  • Pregnant or nursing women.
  • Presence of furcation involvement ≥ II degree (Hamp 1975) at the affected teeth.
  • Very large and wide defects that required the use of membrane.

Exclusion

    Key Trial Info

    Start Date :

    November 2 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    November 2 2025

    Estimated Enrollment :

    38 Patients enrolled

    Trial Details

    Trial ID

    NCT06105125

    Start Date

    November 2 2023

    End Date

    November 2 2025

    Last Update

    November 28 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    CIR Dental School

    Turin, Italy, 10126